3 Health Services Stocks Moving The Industry Upward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading up 27 points (0.2%) at 17,793 as of Tuesday, June 9, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,256 issues advancing vs. 1,750 declining with 142 unchanged.

The Health Services industry currently sits down 0.5% versus the S&P 500, which is up 0.1%. Top gainers within the industry include Grifols ( GRFS), up 1.9%, and CVS Health ( CVS), up 0.7%. On the negative front, top decliners within the industry include Opko Health ( OPK), down 4.5%, and Abbott Laboratories ( ABT), down 0.6%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Intuitive Surgical ( ISRG) is one of the companies pushing the Health Services industry higher today. As of noon trading, Intuitive Surgical is up $5.12 (1.0%) to $495.68 on average volume. Thus far, 121,649 shares of Intuitive Surgical exchanged hands as compared to its average daily volume of 279,900 shares. The stock has ranged in price between $487.44-$495.92 after having opened the day at $489.44 as compared to the previous trading day's close of $490.56.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Intuitive Surgical, Inc. designs, manufactures, and markets da Vinci surgical systems, and related instruments and accessories in the United States, Europe, and Asia. Intuitive Surgical has a market cap of $18.2 billion and is part of the health care sector. Shares are down 6.4% year-to-date as of the close of trading on Monday. Currently there are 9 analysts who rate Intuitive Surgical a buy, no analysts rate it a sell, and 6 rate it a hold.

TheStreet Ratings rates Intuitive Surgical as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, revenue growth and largely solid financial position with reasonable debt levels by most measures. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and weak operating cash flow. Get the full Intuitive Surgical Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

2. As of noon trading, Aetna ( AET) is up $0.64 (0.6%) to $116.64 on light volume. Thus far, 709,729 shares of Aetna exchanged hands as compared to its average daily volume of 2.0 million shares. The stock has ranged in price between $115.94-$117.01 after having opened the day at $116.39 as compared to the previous trading day's close of $116.00.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $40.8 billion and is part of the health care sector. Shares are up 31.6% year-to-date as of the close of trading on Monday. Currently there are 12 analysts who rate Aetna a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, increase in net income, revenue growth and attractive valuation levels. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full Aetna Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

1. As of noon trading, HCA Holdings ( HCA) is up $0.54 (0.7%) to $80.78 on light volume. Thus far, 1.1 million shares of HCA Holdings exchanged hands as compared to its average daily volume of 3.1 million shares. The stock has ranged in price between $80.30-$80.93 after having opened the day at $80.34 as compared to the previous trading day's close of $80.25.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

HCA Holdings, Inc., through its subsidiaries, provides health care services in the United States. HCA Holdings has a market cap of $33.7 billion and is part of the health care sector. Shares are up 9.3% year-to-date as of the close of trading on Monday. Currently there are 16 analysts who rate HCA Holdings a buy, no analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates HCA Holdings as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, compelling growth in net income, revenue growth and good cash flow from operations. We feel its strengths outweigh the fact that the company shows low profit margins. Get the full HCA Holdings Ratings Report now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).

If you liked this article you might like

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Five Rules for This Market Beast: Cramer's 'Mad Money' Recap (Tues 1/16/18)

Warren Buffett Has $100 Billion to Spend, What's He Going to Buy?

Warren Buffett Has $100 Billion to Spend, What's He Going to Buy?

The Method to My Investing Madness: Cramer's 'Mad Money' Recap (Tues 12/26/17)

The Method to My Investing Madness: Cramer's 'Mad Money' Recap (Tues 12/26/17)

CVS Health, Intuitive Surgical, Allergan: 'Mad Money' Lightning Round

CVS Health, Intuitive Surgical, Allergan: 'Mad Money' Lightning Round

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)

Long Live the FAANNG Stocks: Cramer's 'Mad Money' Recap (Tuesday 12/19/17)